Rota virus

Name: Rota virus - Amaris Medical Solutions
Price: 1.00 USD
Availability: InStock

$1.00

WhatsApp Order

Rota virus rapid tests are immunochromatographic assays (CE-marked, FDA-cleared for some brands) for qualitative detection of rotavirus group A antigens in stool specimens, providing results in 10-20 minutes. The test principle uses monoclonal or polyclonal antibodies against rotavirus antigens (typically VP6 protein) immobilized on membranes, capturing antigens that form a visible line. Sensitivity 90-98%, specificity 95-99% compared to ELISA or PCR. The kit includes individually foil-wrapped test devices, sample diluent, and collection applicators. Primary clinical applications include rapid diagnosis of acute gastroenteritis in children (rotavirus is the leading cause of severe diarrhea in under-5 children), outbreak investigation in daycare centers and schools, hospital infection control and isolation precautions, differential diagnosis of acute diarrhea (viral vs. bacterial vs. parasitic), vaccine effectiveness monitoring and surveillance, assessment of dehydration risk, and evaluation of immunocompromised patients. Critical safety precautions include proper specimen collection (clean container, avoid contamination), biological hazard precautions (all stool potentially infectious), quality control verification, and awareness that a negative test does not rule out other causes of gastroenteritis. Essential tool for pediatric gastroenteritis management, infection control, and public health surveillance.

Compare

Add to wishlist

Categories: DIAGNOSTIC EQUIPMENT, Diagnostic Kits, Lab Consumables, LABORATORY EQUIPMENT AND SUPPLIES Tags: Gastroenteritis, Pediatric Diarrhea, Rapid Diagnostic Test, Rota Virus, Rotavirus Test, Stool Antigen Test, Viral Gastroenteritis

Description

Rota virus

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Rapid Diagnosis of Acute Gastroenteritis in Children:

Primary Use: Rotavirus testing is essential for rapid identification of rotavirus infection in infants and young children presenting with acute watery diarrhea, vomiting, fever, and abdominal pain. Rotavirus is the leading cause of severe gastroenteritis in children under 5 years worldwide, and timely diagnosis helps guide appropriate management and prevent unnecessary antibiotic use.
How it helps: Provides worried parents and pediatricians with a quick answer about what is causing their child’s distressing symptoms, distinguishing between viral infections that need supportive care and bacterial infections that require antibiotics.

2. Outbreak Investigation in Daycare Centers and Schools:

Primary Use: Used during suspected outbreaks of gastroenteritis in daycare centers, preschools, and schools to rapidly identify rotavirus as the causative agent, enabling implementation of infection control measures to prevent further transmission.
How it helps: Helps public health officials and school administrators quickly identify the source of an outbreak, allowing them to implement cleaning protocols and isolation measures that stop the spread to more children and families.

3. Hospital Infection Control and Isolation Precautions:

Primary Use: Positive rotavirus testing allows for prompt initiation of contact precautions in hospitalized children, preventing nosocomial spread of the virus to other vulnerable pediatric patients.
How it helps: Protects hospitalized children from catching a second infection while they are already ill, keeping rotavirus from spreading through pediatric wards and putting other young patients at risk.

4. Differential Diagnosis of Acute Diarrhea:

Primary Use: Rotavirus testing helps distinguish viral gastroenteritis from bacterial (Salmonella, Shigella, Campylobacter, E. coli) or parasitic (Giardia, Cryptosporidium) causes of diarrhea, guiding appropriate treatment and avoiding inappropriate antibiotic therapy.
How it helps: Prevents unnecessary antibiotic use in children with viral infections, sparing them from side effects and helping combat the growing problem of antibiotic resistance.

5. Vaccine Effectiveness Monitoring and Surveillance:

Primary Use: Used in public health surveillance programs to monitor the effectiveness of rotavirus vaccination programs, track circulating strains, and detect breakthrough infections in vaccinated populations.
How it helps: Provides essential data that helps public health officials understand how well rotavirus vaccines are working, identifying any gaps in protection and guiding future vaccination strategies.

6. Assessment of Dehydration Risk and Severity:

Primary Use: Confirmation of rotavirus infection helps clinicians anticipate the clinical course, as rotavirus gastroenteritis is associated with higher risk of severe dehydration and hospitalization compared to some other viral causes, guiding more aggressive fluid management.
How it helps: Alerts doctors to the higher risk of dehydration in rotavirus infections, prompting them to be more aggressive with fluid replacement and closer monitoring to prevent children from becoming dangerously dehydrated.

7. Evaluation of Immunocompromised Patients:

Primary Use: Testing for rotavirus is important in immunocompromised children and adults (e.g., transplant recipients, oncology patients, HIV-infected) who may develop prolonged, severe, or disseminated infection requiring specific management.
How it helps: Identifies rotavirus as the cause of diarrhea in vulnerable patients whose immune systems cannot fight off infection normally, allowing for specialized management and closer monitoring to prevent complications.

SECONDARY & SUPPORTIVE USES

1. Travel Medicine: Used to evaluate returning travelers from endemic areas presenting with acute diarrhea, though other enteric pathogens are more common in adults, helping diagnose imported infections.

2. Foodborne Illness Investigations: May be included in foodborne outbreak investigations, though rotavirus is typically person-to-person transmitted rather than foodborne, helping rule out viral causes.

3. Research and Epidemiological Studies: Used in studies investigating rotavirus prevalence, seasonality, genetic diversity, and vaccine impact, contributing to scientific understanding and better prevention strategies.

4. Neonatal Intensive Care Unit (NICU) Screening: May be used to investigate outbreaks of diarrhea in NICUs, where rotavirus can cause significant morbidity in premature infants, protecting the most vulnerable patients.

5. Emergency Department Triage: Rapid testing helps identify rotavirus-positive children who may require isolation from other patients in busy emergency settings, preventing spread in crowded waiting rooms.

6. Pediatric Ward Admission Screening: Some hospitals screen children admitted with gastroenteritis to guide cohorting and isolation decisions, keeping rotavirus from spreading through pediatric units.

7. Clinical Trials for Antiviral or Vaccine Studies: Used to confirm rotavirus infection in participants enrolled in clinical trials of new antivirals or vaccines, supporting the development of new tools to fight this common childhood illness.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Test Type: Rapid immunochromatographic test for qualitative detection of rotavirus antigens in stool specimens.
Common Names: Rotavirus Test, Rotavirus Antigen Test, Rotavirus Rapid Test, Rota Strip.
Sample Type: Fresh stool specimen (formed, semi-formed, or liquid).
Detection Target: Rotavirus group A antigens (VP6 protein most common).
Test Time: 10-20 minutes.
Test Principle: Immunochromatography; monoclonal or polyclonal antibodies against rotavirus antigens immobilized on membrane capture antigens from processed stool sample, producing visible line.
Internal Control: Built-in procedural control line confirms test validity; no control line = invalid test.

2. TECHNICAL & PERFORMANCE PROPERTIES

Sensitivity: 90-98% compared to reference methods (ELISA or PCR).
Specificity: 95-99% (minimal cross-reactivity with other enteric viruses or bacteria).
Detection Limit: Typically detects 10^6-10^7 virus particles per mL of stool.
Test Principle: Double-antibody sandwich immunochromatography; antibodies against rotavirus antigens conjugated to colloidal gold capture antigens in stool sample.
Cross-Reactivity: Validated against common enteric pathogens (adenovirus, astrovirus, norovirus, Salmonella, Shigella, Campylobacter, E. coli) to ensure specificity.
Prozone Effect: Very high antigen concentrations may cause false-negative results (rare).

3. PHYSICAL & OPERATIONAL PROPERTIES

Test Device: Plastic cassette with sample well and result window, or dipstick format.
Kit Components:
- Test Devices: Individually foil-wrapped with desiccant.
- Sample Diluent/Buffer: For stool processing and application.
- Collection Tubes/Applicators: For stool sample collection and transfer.
- Package Insert: Instructions for use and interpretation.
- Positive and Negative Controls: Available separately or in some kits.
Sample Volume: 50-100 mg of stool or 50-100 µL of liquid stool.
Result Interpretation:
- Negative: Only control line visible.
- Positive: Both control and test lines visible.
- Invalid: No control line visible.
Packaging Sizes: 10, 20, 25, or 50 tests per kit.
Shelf Life: 18-24 months from manufacture date.
Storage Temperature: 2-30°C (room temperature); protect from humidity and direct sunlight; do not freeze.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: CE marked for IVD use; FDA cleared for certain brands; WHO prequalified for some tests.
Quality Control: Built-in procedural control in each test; external controls recommended with each new lot.
Biohazard Precautions: All stool specimens potentially infectious for enteric pathogens (Salmonella, Shigella, Campylobacter, hepatitis A, norovirus, rotavirus).
Chemical Safety: Buffer contains preservatives; avoid contact with eyes and skin.
Disposal: Used tests and contaminated materials disposed as biohazardous waste.
Reporting: Rotavirus is a reportable disease in some jurisdictions; positive results may require notification to public health authorities.

5. STORAGE & HANDLING ATTRIBUTES

Storage Temperature: 2-30°C; do not freeze; protect from humidity and direct sunlight.
Sample Handling: Test fresh stool within 24 hours if stored at 2-8°C; freeze at -20°C for longer storage (avoid repeated freeze-thaw).
Test Preparation: Bring test devices and samples to room temperature before testing.
Specimen Collection: Collect stool in a clean, dry container; avoid contamination with urine, water, or toilet paper.
Expiration: Never use tests beyond expiration date; results invalid.
Quality Control: Test external controls with each new lot and as required by laboratory protocol.
Disposal: Dispose of contaminated materials in biohazard containers.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: Rapid point-of-care detection of rotavirus antigens in stool specimens for diagnosis of rotavirus gastroenteritis in children and adults.
Testing Indications:
- Acute watery diarrhea in infants and young children.
- Suspected outbreak in daycare centers, schools, or institutions.
- Hospitalized children with diarrhea for infection control.
- Immunocompromised patients with gastroenteritis.
- Differential diagnosis of acute diarrhea (viral vs. bacterial vs. parasitic).
Interpretation:
- Positive: Indicates rotavirus infection; manage with supportive care (fluids, electrolytes), isolation precautions.
- Negative: Does not rule out other viral, bacterial, or parasitic causes; consider additional testing.
- Invalid: Repeat with new device; if persists, collect new sample.
Limitations: Detects only rotavirus group A (most common); does not detect other viral causes (norovirus, adenovirus, astrovirus); sensitivity lower in adults due to lower viral shedding.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Biological Hazard: Stool specimens potentially infectious; wear gloves and appropriate PPE.
Hand Hygiene: Wash hands thoroughly after handling specimens and test devices.
Specimen Collection: Use clean, dry containers; avoid contamination with urine, water, or toilet paper.
Quality Control: Always verify control line appears; no control line = invalid test.
Clinical Correlation: Negative test does not rule out other causes of gastroenteritis.
Pediatric Use: Safe for all ages; sample collection may require assistance from a caregiver.
Storage Compliance: Store tests at recommended temperature; heat/humidity degrades components.
Expiration: Never use expired tests; accuracy compromised.

2. FIRST AID MEASURES

Specimen Spill: Contain with absorbent material; disinfect area with 10% bleach solution; dispose as biohazard waste.
Buffer Contact (Eyes): Flush eyes with copious water for 15 minutes; seek medical attention.
Buffer Ingestion: Contact poison control center; do not induce vomiting unless instructed.
Skin Contact with Specimen: Wash affected area thoroughly with soap and water.

3. FIRE FIGHTING MEASURES

Flammability: Plastic components and packaging are combustible.
Extinguishing Media: Use water, foam, CO₂, or dry chemical as appropriate.

Rota virus

Rota virus

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Rapid Diagnosis of Acute Gastroenteritis in Children:

How it helps: Provides worried parents and pediatricians with a quick answer about what is causing their child’s distressing symptoms, distinguishing between viral infections that need supportive care and bacterial infections that require antibiotics.

2. Outbreak Investigation in Daycare Centers and Schools:

Primary Use: Used during suspected outbreaks of gastroenteritis in daycare centers, preschools, and schools to rapidly identify rotavirus as the causative agent, enabling implementation of infection control measures to prevent further transmission.

How it helps: Helps public health officials and school administrators quickly identify the source of an outbreak, allowing them to implement cleaning protocols and isolation measures that stop the spread to more children and families.

3. Hospital Infection Control and Isolation Precautions:

Primary Use: Positive rotavirus testing allows for prompt initiation of contact precautions in hospitalized children, preventing nosocomial spread of the virus to other vulnerable pediatric patients.

How it helps: Protects hospitalized children from catching a second infection while they are already ill, keeping rotavirus from spreading through pediatric wards and putting other young patients at risk.

4. Differential Diagnosis of Acute Diarrhea:

Primary Use: Rotavirus testing helps distinguish viral gastroenteritis from bacterial (Salmonella, Shigella, Campylobacter, E. coli) or parasitic (Giardia, Cryptosporidium) causes of diarrhea, guiding appropriate treatment and avoiding inappropriate antibiotic therapy.

How it helps: Prevents unnecessary antibiotic use in children with viral infections, sparing them from side effects and helping combat the growing problem of antibiotic resistance.

5. Vaccine Effectiveness Monitoring and Surveillance:

Primary Use: Used in public health surveillance programs to monitor the effectiveness of rotavirus vaccination programs, track circulating strains, and detect breakthrough infections in vaccinated populations.

How it helps: Provides essential data that helps public health officials understand how well rotavirus vaccines are working, identifying any gaps in protection and guiding future vaccination strategies.

6. Assessment of Dehydration Risk and Severity:

Primary Use: Confirmation of rotavirus infection helps clinicians anticipate the clinical course, as rotavirus gastroenteritis is associated with higher risk of severe dehydration and hospitalization compared to some other viral causes, guiding more aggressive fluid management.

How it helps: Alerts doctors to the higher risk of dehydration in rotavirus infections, prompting them to be more aggressive with fluid replacement and closer monitoring to prevent children from becoming dangerously dehydrated.

7. Evaluation of Immunocompromised Patients:

Primary Use: Testing for rotavirus is important in immunocompromised children and adults (e.g., transplant recipients, oncology patients, HIV-infected) who may develop prolonged, severe, or disseminated infection requiring specific management.

How it helps: Identifies rotavirus as the cause of diarrhea in vulnerable patients whose immune systems cannot fight off infection normally, allowing for specialized management and closer monitoring to prevent complications.

SECONDARY & SUPPORTIVE USES

1. Travel Medicine: Used to evaluate returning travelers from endemic areas presenting with acute diarrhea, though other enteric pathogens are more common in adults, helping diagnose imported infections.

2. Foodborne Illness Investigations: May be included in foodborne outbreak investigations, though rotavirus is typically person-to-person transmitted rather than foodborne, helping rule out viral causes.

3. Research and Epidemiological Studies: Used in studies investigating rotavirus prevalence, seasonality, genetic diversity, and vaccine impact, contributing to scientific understanding and better prevention strategies.

4. Neonatal Intensive Care Unit (NICU) Screening: May be used to investigate outbreaks of diarrhea in NICUs, where rotavirus can cause significant morbidity in premature infants, protecting the most vulnerable patients.

5. Emergency Department Triage: Rapid testing helps identify rotavirus-positive children who may require isolation from other patients in busy emergency settings, preventing spread in crowded waiting rooms.

6. Pediatric Ward Admission Screening: Some hospitals screen children admitted with gastroenteritis to guide cohorting and isolation decisions, keeping rotavirus from spreading through pediatric units.

7. Clinical Trials for Antiviral or Vaccine Studies: Used to confirm rotavirus infection in participants enrolled in clinical trials of new antivirals or vaccines, supporting the development of new tools to fight this common childhood illness.

1. BASIC IDENTIFICATION ATTRIBUTES

Test Type: Rapid immunochromatographic test for qualitative detection of rotavirus antigens in stool specimens.

Common Names: Rotavirus Test, Rotavirus Antigen Test, Rotavirus Rapid Test, Rota Strip.

Sample Type: Fresh stool specimen (formed, semi-formed, or liquid).

Detection Target: Rotavirus group A antigens (VP6 protein most common).

Test Time: 10-20 minutes.

Test Principle: Immunochromatography; monoclonal or polyclonal antibodies against rotavirus antigens immobilized on membrane capture antigens from processed stool sample, producing visible line.

Internal Control: Built-in procedural control line confirms test validity; no control line = invalid test.

2. TECHNICAL & PERFORMANCE PROPERTIES

Sensitivity: 90-98% compared to reference methods (ELISA or PCR).

Specificity: 95-99% (minimal cross-reactivity with other enteric viruses or bacteria).

Detection Limit: Typically detects 10^6-10^7 virus particles per mL of stool.

Test Principle: Double-antibody sandwich immunochromatography; antibodies against rotavirus antigens conjugated to colloidal gold capture antigens in stool sample.

Cross-Reactivity: Validated against common enteric pathogens (adenovirus, astrovirus, norovirus, Salmonella, Shigella, Campylobacter, E. coli) to ensure specificity.

Prozone Effect: Very high antigen concentrations may cause false-negative results (rare).

3. PHYSICAL & OPERATIONAL PROPERTIES

Test Device: Plastic cassette with sample well and result window, or dipstick format.

Kit Components:

Test Devices: Individually foil-wrapped with desiccant.

Sample Diluent/Buffer: For stool processing and application.

Collection Tubes/Applicators: For stool sample collection and transfer.

Package Insert: Instructions for use and interpretation.

Positive and Negative Controls: Available separately or in some kits.

Sample Volume: 50-100 mg of stool or 50-100 µL of liquid stool.

Result Interpretation:

Negative: Only control line visible.

Positive: Both control and test lines visible.

Invalid: No control line visible.

Packaging Sizes: 10, 20, 25, or 50 tests per kit.

Shelf Life: 18-24 months from manufacture date.

Storage Temperature: 2-30°C (room temperature); protect from humidity and direct sunlight; do not freeze.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: CE marked for IVD use; FDA cleared for certain brands; WHO prequalified for some tests.

Quality Control: Built-in procedural control in each test; external controls recommended with each new lot.

Biohazard Precautions: All stool specimens potentially infectious for enteric pathogens (Salmonella, Shigella, Campylobacter, hepatitis A, norovirus, rotavirus).

Chemical Safety: Buffer contains preservatives; avoid contact with eyes and skin.

Disposal: Used tests and contaminated materials disposed as biohazardous waste.

Reporting: Rotavirus is a reportable disease in some jurisdictions; positive results may require notification to public health authorities.

5. STORAGE & HANDLING ATTRIBUTES

Storage Temperature: 2-30°C; do not freeze; protect from humidity and direct sunlight.

Sample Handling: Test fresh stool within 24 hours if stored at 2-8°C; freeze at -20°C for longer storage (avoid repeated freeze-thaw).

Test Preparation: Bring test devices and samples to room temperature before testing.

Specimen Collection: Collect stool in a clean, dry container; avoid contamination with urine, water, or toilet paper.

Expiration: Never use tests beyond expiration date; results invalid.

Quality Control: Test external controls with each new lot and as required by laboratory protocol.

Disposal: Dispose of contaminated materials in biohazard containers.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: Rapid point-of-care detection of rotavirus antigens in stool specimens for diagnosis of rotavirus gastroenteritis in children and adults.

Testing Indications: